Guselkumab, a human interleukin-23 monoclonal antibody in Japanese patients with generalized pustular psoriasis and erythrodermic psoriasis: Efficacy and safety analyses of a 52-week, phase 3, multicenter, open-label study.
- Shigetoshi Sano,
- Hiroshi Kubo,
- Hitomi Morishima,
- Ryosuke Goto,
- Richuan Zheng,
- Hidemi Nakagawa
J Dermatol 2018 May 22;45(5):529-539. Epub 2018 Mar 22.
Department of Dermatology, The Jikei University School of Medicine, Tokyo, Japan.